Bioventix PLC LSE:BVXP.L

Bioventix stock price today

GBP 3,400
+200
+6.25%
Financial Health
0
1
2
3
4
5
6
7
8
9

Bioventix stock price monthly change

-22.89%
month

Bioventix stock price quarterly change

-22.89%
quarter

Bioventix stock price yearly change

-25.58%
year

Bioventix key metrics

Market Cap
165.46M
Enterprise value
157.24M
P/E
20.16
EV/Sales
11.55
EV/EBITDA
14.80
Price/Sales
11.99
Price/Book
13.60
PEG ratio
74.60
EPS
2.66
Revenue
21.85M
EBITDA
17.18M
Income
13.88M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
59.51%
Oper. margin
77.89%
Gross margin
92.79%
EBIT margin
77.89%
EBITDA margin
78.63%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Bioventix stock price history

Bioventix stock forecast

Bioventix financial statements

Bioventix PLC (LSE:BVXP.L): Profit margin
Dec 2021 2.36M 1.49M 63.16%
Dec 2022 5.89M 3.73M 63.28%
Jun 2023 6.92M 4.64M 67.07%
Dec 2023 6.67M 4.02M 60.28%
4.95%
Yield TTM
Bioventix PLC (LSE:BVXP.L): Payout ratio
Payout ratio 101.86%
Bioventix PLC (LSE:BVXP.L): Dividend Yield
2016 3.96%
2017 3.46%
2019 3.21%
2020 3.03%
2022 4.41%
Bioventix PLC (LSE:BVXP.L): Debt to assets
Dec 2021 10628856 900.19K 8.47%
Sep 2022 11710173 1.22M 10.43%
Dec 2022 11710173 1.24M 10.63%
Dec 2023 13148538 1.71M 13.04%
Bioventix PLC (LSE:BVXP.L): Cash Flow
Dec 2021 3.76M -3.31K -5.20M
Dec 2022 4.24M -10.58K -5.20M
Jun 2023 3.66M 65.75K -3.09M
Dec 2023 4.49M -5.32K -4.69M

Bioventix alternative data

Bioventix PLC (LSE:BVXP.L): Employee count
Aug 2023 12
Sep 2023 12
Oct 2023 12
Nov 2023 12
Dec 2023 12
Jan 2024 12
Feb 2024 12
Mar 2024 12
Apr 2024 12
May 2024 12
Jun 2024 12
Jul 2024 12

Bioventix other data

Insider Compensation
Mr. Peter John Harrison MA (1958) Chief Executive Officer & Director
$270,810
Mr. Bruce Edward Heath Hiscock (1958) Chief Financial Officer & Director
$61,660
  • What's the price of Bioventix stock today?

    One share of Bioventix stock can currently be purchased for approximately $3,400.

  • When is Bioventix's next earnings date?

    Unfortunately, Bioventix's (BVXP.L) next earnings date is currently unknown.

  • Does Bioventix pay dividends?

    Yes, Bioventix pays dividends and its trailing 12-month yield is 4.96% with 102% payout ratio.It means that the company is paying a dividend greater than earnings. The last Bioventix stock dividend of $0 was paid on 3 Sep 2025.

  • How much money does Bioventix make?

    Bioventix has a market capitalization of 165.46M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.1% to 13.61M US dollars.

  • What is Bioventix's stock symbol?

    Bioventix PLC is traded on the LSE under the ticker symbol "BVXP.L".

  • What is Bioventix's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Bioventix?

    Shares of Bioventix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Bioventix's key executives?

    Bioventix's management team includes the following people:

    • Mr. Peter John Harrison MA Chief Executive Officer & Director(age: 67, pay: $270,810)
    • Mr. Bruce Edward Heath Hiscock Chief Financial Officer & Director(age: 67, pay: $61,660)
  • How many employees does Bioventix have?

    As Jul 2024, Bioventix employs 12 workers.

  • When Bioventix went public?

    Bioventix PLC is publicly traded company for more then 11 years since IPO on 29 Apr 2014.

  • What is Bioventix's official website?

    The official website for Bioventix is bioventix.com.

  • How can i contact Bioventix?

    Bioventix can be reached via phone at +44 1252 728001.

Bioventix company profile:

Bioventix PLC

bioventix.com
Exchange:

LSE

Full time employees:

12

Industry:

Biotechnology

Sector:

Healthcare

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.

27–28 Eastcastle Street
London, W1W 8DH

:
ISIN: GB00B4QVDF07
CUSIP: G1285U100